Decline in the Value of Investments and Impairment
First written in FY2016. 6 of 8 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2019: 10 of 27 companies on the "Worse" side.
14 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「If the synergies initially anticipated fail to materialise, or the target company's business growth or profitability fails to meet expectations, the investment securities and other assets acquired may require impairment due to a decline in share prices or intrinsic value, which could affect the Group's financial results.」
The company reconfirmed the risk of impairment if investments fail to deliver the expected synergies, growth or profitability. No impairment loss on securities was recorded during the current fiscal year. - FY2024RestatedAnnual report
「If the synergies initially anticipated fail to materialise, or the target company's business growth or profitability fails to meet expectations, the investment securities and other assets acquired may require impairment due to a decline in share prices or intrinsic value, which could affect the Group's financial results.」
The company reconfirmed the risk of impairment if investments fail to deliver the expected synergies, growth or profitability. No impairment loss was recorded during the current fiscal year. - FY2023RestatedAnnual report
「If the synergies initially anticipated fail to materialise, or the target company's business growth or profitability fails to meet expectations, the investment securities and other assets acquired may require impairment due to a decline in share prices or intrinsic value, which could affect the Group's financial results.」
The company reiterated the risk of impairment if investments fail to deliver the expected synergies, growth or profitability. No impairment loss on securities was recorded during the current fiscal year. - FY2022RestatedAnnual report
「If the synergies initially anticipated fail to materialise, or the target company's business growth or profitability fails to meet expectations, the investment securities and other assets acquired may require impairment due to a decline in share prices or intrinsic value, which could affect the Group's financial results.」
The company reiterated the risk of impairment if investments fail to deliver the expected synergies, growth or profitability. No impairment loss on securities was recorded during the current fiscal year. - FY2020MaterialisedAnnual report
「During the current consolidated fiscal year, the company recorded a valuation loss of ¥102.177 million on some of its investment securities.」
The company recorded a valuation loss of ¥102.177 million on some investment securities, meaning the risk of a decline in the value of investments and impairment materialised as an actual loss. - FY2018RestatedAnnual report
「If the synergies initially anticipated fail to materialise, or the target company's business growth or profitability fails to meet expectations, the investment securities and other assets acquired may require impairment due to a decline in share prices or intrinsic value, which could affect the Group's financial results.」
The company reiterated the risk of impairment if investments in IT companies and customers or partner companies fail to deliver the expected synergies or growth. - FY2017RestatedAnnual report
「If the synergies initially anticipated fail to materialise, or the target company's business growth or profitability fails to meet expectations, the investment securities and other assets acquired may require impairment due to a decline in share prices or intrinsic value, which could affect the Group's financial results.」
The company reiterated the risk of impairment if investments in IT companies and customers or partner companies fail to deliver the expected synergies or growth. - FY2016First statedAnnual report
「If the synergies initially anticipated fail to materialise, or the target company's business growth or profitability fails to meet expectations, the investment securities and other assets acquired may require impairment due to a decline in share prices or intrinsic value.」
For investments in companies made in anticipation of future technologies and synergies, the company identifies impairment if expectations are not met as a risk.